Amanta Healthcar

48
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE084K01015
  • NSEID: AMANTA
  • BSEID: 544502
INR
223.60
-15.35 (-6.42%)
BSENSE

Nov 20

BSE+NSE Vol: 2.19 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 4.72% vs -2.01% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 0.32% vs 3.79% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -25.77% vs -16.92% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 41.66% vs 189.02% in Mar 2025

Compare Profit and Loss Results of Amanta Healthcar
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
287.00
93.00
194.00
208.60%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
287.00
93.00
194.00
208.60%
Expenditure (Ex Depriciation)
Stock Adjustments
-10.00
0.00
-10.00
0%
Raw Materials Consumed
107.00
41.00
66.00
160.98%
Power & Fuel Cost
22.00
0.00
22.00
0%
Employee Cost
42.00
8.00
34.00
425.00%
Operating Expenses
25.00
3.00
22.00
733.33%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
25.00
0.00
25.00
0%
Cost of Software developments
0.00
2.00
-2.00
-100.00%
Miscellaneous Expenses
4.00
0.00
4.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
227.00
64.00
163.00
254.69%
Operating Profit (PBDIT) excl Other Income
59.00
29.00
30.00
103.45%
Other Income
3.00
6.00
-3.00
-50.00%
Operating Profit (PBDIT)
63.00
36.00
27.00
75.00%
Interest
20.00
0.00
20.00
0%
Profit before Depriciation and Tax
42.00
35.00
7.00
20.00%
Depreciation
18.00
2.00
16.00
800.00%
Profit Before Taxation & Exceptional Items
23.00
33.00
-10.00
-30.30%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
21.00
33.00
-12.00
-36.36%
Provision for Tax
6.00
8.00
-2.00
-25.00%
Profit After Tax
14.00
24.00
-10.00
-41.67%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
28.00
44.00
-16.00
-36.36%
Profit Available for appropriations
43.00
68.00
-25.00
-36.76%
Appropriations
43.00
68.00
-25.00
-36.76%
Equity Dividend (%)
0%
5%
-5.00
Earnings Per Share
4.33
20.96
-16.63
-79.34%
Profit And Loss - Net Sales
Net Sales 287.68 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 4.72% vs -2.01% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 59.86 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 0.32% vs 3.79% in Mar 2025

Profit And Loss - Interest
Interest 20.75 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -25.77% vs -16.92% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 14.88 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 41.66% vs 189.02% in Mar 2025